drug protocol number

2231281

drug sponsor

King Faisal Specialist Hospital & Research Centre Riyadh, Saudi Arabia

drug study

Empagliflozin

drug trial site

King Faisal Specialist Hospital and Research Center (Riyadh)

drug status

Ongoing

drug phase